Survival impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in head and neck cancer.
William A StokesElizabeth MolinaJessica D McDermottRustain L MorganThomas BickettKareem R FakhouryArya AminiSana D KaramPublished in: Head & neck (2021)
ARB usage is associated with improved OS and CSS among HNC patients with CKD or HTN.